Bioequivalence of Generic Drugs and Biosimilars

Bioequivalence of generic drugs and biosimilars refers to demonstrating comparable pharmacokinetic and pharmacodynamic properties to their respective reference products. For generic drugs, this involves proving similarity in rate and extent of drug absorption, typically through comparative bioavailability studies

 

    Related Conference of Bioequivalence of Generic Drugs and Biosimilars

    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    April 08-09, 2027

    21st World Drug Delivery Summit

    Vienna, Austria
    April 12-13, 2027

    23rd Annual Congress on Pharmacology and Toxicology

    Amsterdam, Netherlands
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France
    April 27-28, 2027

    19th World Drug Delivery Summit

    Paris, France

    Bioequivalence of Generic Drugs and Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in